SUMMARY Clq-binding immune complexes (CIC), anti-IgG antibodies (anti-IgG Ab), and complement levels were investigated in the serum of 37 patients with ankylosing spondylitis (AS). In all these studies the mean levels observed in patients with AS were similar to those in 31 normal subjects. Moreover, no significative difference in either CIC or anti-IgG Ab levels was observed when the patients were classified in different clinical forms according to the localisation (peripheral and central) or to the gravity (mild and severe) of the AS. In a parallel study increased CIC and anti-IgG Ab levels were found in most of the 81 patients with seropositive or seronegative rheumatoid arthritis.
Most cases of inflammatory arthritis are thought to be associated with immunopathological disorders. Rheumatoid arthritis (RA) represents the classical example of this association, in which circulating immune complexes (CIC), rheumatoid factor (RF), and complement appear to play an important role in the pathogenesis of the disease.'-3 In ankylosing spondylitis (AS), despite some features in common with RA such as the occurrence of histologically nonspecific chronic inflammation, there is no clear evidence of immunopathological involvement. Howell and others4 showed the presence of antigammaglobulin antibodies in patients with AS.
More recently Gabay and others,5 using the 1251-Clq binding test, found a weak level of CXC in only a few patients with AS. Moreover, these authors were unable to detect any change in the complement catabolism of these patients. On the other hand Corrigall et al.,6 by using the inhibition of antibodymediated lymphocyte-induced cytotoxicity, demonstrated CIC in more than 50% of AS patients. Finally, the association between AS and HLA B27 histocompatibility antigen7 is an other argument for a possible immunological origin of this disease.
The purpose of the present work was to investigate 
Results

CIRCULATING IMMUNE COMPLEXES
No significant difference in the mean of Clq-binding activity was observed between the AS patients and the healthy subjects (Table 1) . Only 4 patients with AS ( Fig. 1) showed a Clq-binding activity discretely higher than the normal subjects (mean ± 2 SD). Among them 3 had a peripheral form and the last one a central form. As regards illness, 2 were mild and 2 severe. In contrast, most of the RA + and RA-patients showed an increased Clq-binding activity (Fig. 1 ).
ANTI-IgG ANTIBODIES
Anti-IgG Ab were investigated by 3 different techniques. All the patients with AS gave negative results for rheumatoid factor by both the WaalerRose and latex tests. By using the RIPEGA the mean level of 1251-IgG precipitation in AS patients was not different from that obtained with normal subjects (Table 1) . Nevertheless, 3 patients with AS showed anti-IgG Ab levels higher than the mean ±-2 SD of normal subjects (Fig. 2) . They had respectively 1 central and 2 peripheral forms and 2 severe and 1 mild form. These patients showed no Clq-binding Gabay and others,5 by using the same method employed in our study, i.e., the 1251-Clq binding test, found only slightly significant CIC levels in 14% of the tested patients with AS. The levels of complement and some of its components in AS patients did not differ from the normal range. These data are in agreement with most of the work in AS.'4 16All these observations weigh against the presence of CIC in AS patients. The failure to find CIC and anti-IgG Ab in AS suggests the pathology differs from that observed in RA. 
